Litcius/Paper detail

Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation

Leila Asadollahi, Amin Mahoutforoush, Seyed Sina Dorreyatim, Tannaz Soltanfam, Ana Cláudia Paiva‐Santos, Diana Peixoto, Francisco Veiga, Hamed Hamishehkar, Mahdi Zeinali, Soheil Abbaspour‐Ravasjani

2022International Journal of Pharmaceutics64 citationsDOI

Topics & Concepts

ResveratrolApoptosisSurvivinViability assayChemistryDAPICytotoxicityPharmacologyCell growthDrug deliveryCaspase 3In vitroCancer researchMedicineBiochemistryProgrammed cell deathOrganic chemistryRNA Interference and Gene DeliveryCell death mechanisms and regulationToxin Mechanisms and Immunotoxins
Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation | Litcius